1 January - 30 June (unaudited)
|
kEUR |
Note |
H1 2023 |
H1 2022 |
|
|
|
|
|
|
Result for the period |
|
-34,266 |
10,247 |
|
|
|
|
|
|
Other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Exchange differences on translation of foreign operations, net of tax |
|
-5,720 |
8,840 |
|
Net other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
-5,720 |
8,840 |
|
|
|
|
|
|
Other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Remeasurement gain / (loss) on defined benefit plans |
|
2,892 |
10,028 |
|
Income tax effect |
|
-661 |
-2,338 |
|
Net other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
2,231 |
7,690 |
|
Other comprehensive result for the period, net of taxes |
|
-3,489 |
16,530 |
|
|
|
|
|
|
Total comprehensive result for the period, net of taxes |
|
-37,755 |
26,777 |
|
|
|
|
|
|
Attributable to shareholders of PolyPeptide Group AG |
|
-37,755 |
26,777 |